158 related articles for article (PubMed ID: 36812242)
1. Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
Ohmichi T; Kasai T; Shinomoto M; Kitani-Morii F; Fujino Y; Menjo K; Mizuno T
PLoS One; 2023; 18(2):e0282153. PubMed ID: 36812242
[TBL] [Abstract][Full Text] [Related]
2. Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.
Yoshida T; Shimodaira Y; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
Tohoku J Exp Med; 2022 Jul; 257(4):301-308. PubMed ID: 35598974
[TBL] [Abstract][Full Text] [Related]
3. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
4. Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
Fujimoto M; Serada S; Suzuki K; Nishikawa A; Ogata A; Nanki T; Hattori K; Kohsaka H; Miyasaka N; Takeuchi T; Naka T
Arthritis Rheumatol; 2015 May; 67(8):2056-60. PubMed ID: 25917892
[TBL] [Abstract][Full Text] [Related]
5. Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.
Takenaka K; Kitazume Y; Kawamoto A; Fujii T; Udagawa Y; Wanatabe R; Shimizu H; Hibiya S; Nagahori M; Ohtsuka K; Sato H; Hirakawa A; Watanabe M; Okamoto R
Am J Gastroenterol; 2023 Jun; 118(6):1028-1035. PubMed ID: 36571769
[TBL] [Abstract][Full Text] [Related]
6. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
Serada S; Fujimoto M; Terabe F; Iijima H; Shinzaki S; Matsuzaki S; Ohkawara T; Nezu R; Nakajima S; Kobayashi T; Plevy SE; Takehara T; Naka T
Inflamm Bowel Dis; 2012 Nov; 18(11):2169-79. PubMed ID: 22374925
[TBL] [Abstract][Full Text] [Related]
7. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
[TBL] [Abstract][Full Text] [Related]
9. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
Shinzaki S; Matsuoka K; Tanaka H; Takeshima F; Kato S; Torisu T; Ohta Y; Watanabe K; Nakamura S; Yoshimura N; Kobayashi T; Shiotani A; Hirai F; Hiraoka S; Watanabe M; Matsuura M; Nishimoto S; Mizuno S; Iijima H; Takehara T; Naka T; Kanai T; Matsumoto T
J Gastroenterol; 2021 Jun; 56(6):560-569. PubMed ID: 33942166
[TBL] [Abstract][Full Text] [Related]
10. Serum leucine-rich α2-glycoprotein as a possible marker for inflammatory status in endometriosis.
Kobayashi M; Nakamura O; Kitahara Y; Inoue N; Tsukui Y; Hasegawa Y; Hiraishi H; Yabuki A; Muraoka A; Osuka S; Iwase A
Reprod Med Biol; 2023; 22(1):e12536. PubMed ID: 37608861
[TBL] [Abstract][Full Text] [Related]
11. Significance of Serum Leucine-rich Alpha-2 Glycoprotein as a Diagnostic Marker in Pediatric Inflammatory Bowel Disease.
Yoshimura S; Okata Y; Ooi M; Horinouchi T; Iwabuchi S; Kameoka Y; Watanabe A; Kondo A; Uemura K; Tomioka Y; Samejima Y; Nakai Y; Nozu K; Kodama Y; Bitoh Y
Kobe J Med Sci; 2024 Jan; 69(4):E122-E128. PubMed ID: 38379274
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A
Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589
[TBL] [Abstract][Full Text] [Related]
13. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
[TBL] [Abstract][Full Text] [Related]
14. Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.
Ishida T; Kotani T; Serada S; Fujimoto M; Takeuchi T; Makino S; Naka T
PLoS One; 2020; 15(6):e0234090. PubMed ID: 32479560
[TBL] [Abstract][Full Text] [Related]
15. Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.
Abe I; Shiga H; Chiba H; Miyazawa T; Oomori S; Shimoyama Y; Moroi R; Kuroha M; Kakuta Y; Kinouchi Y; Masamune A
J Gastroenterol Hepatol; 2022 Sep; 37(9):1741-1748. PubMed ID: 35641439
[TBL] [Abstract][Full Text] [Related]
16. Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
Umezawa N; Mizoguchi F; Maejima Y; Kimura N; Hasegawa H; Hosoya T; Fujimoto M; Kohsaka H; Naka T; Yasuda S
Front Med (Lausanne); 2023; 10():1153883. PubMed ID: 37215715
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
Kawamura T; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Iida T; Mizutani Y; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M
Inflamm Bowel Dis; 2023 Feb; 29(2):245-253. PubMed ID: 35436345
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis.
Ha YJ; Kang EJ; Lee SW; Lee SK; Park YB; Song JS; Choi ST
J Korean Med Sci; 2014 Sep; 29(9):1199-204. PubMed ID: 25246736
[TBL] [Abstract][Full Text] [Related]
19. LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease.
Naka T; Fujimoto M
Immunol Med; 2018 Jun; 41(2):62-67. PubMed ID: 30938267
[TBL] [Abstract][Full Text] [Related]
20. The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein.
Nakajima H; Nakajima K; Takaishi M; Ohko K; Serada S; Fujimoto M; Naka T; Sano S
J Immunol; 2021 Apr; 206(7):1469-1477. PubMed ID: 33648938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]